Tristar Acquisition I Corp - Ordinary Shares (TRIS) 10-Q 14 Aug 23 2023 Q2 Quarterly report Financial data

Cover

Cover - shares	6 Months Ended
	Jun. 30, 2023	Aug. 14, 2023
Document Information Line Items
Entity Registrant Name	TRISTAR ACQUISITION I CORP.
Entity Central Index Key	0001852736
Document Type	10-Q
Amendment Flag	false
Current Fiscal Year End Date	--12-31
Entity Small Business	true
Entity Shell Company	true
Entity Emerging Growth Company	true
Entity Current Reporting Status	Yes
Document Period End Date	Jun. 30, 2023
Entity Filer Category	Non-accelerated Filer
Document Fiscal Period Focus	Q2
Document Fiscal Year Focus	2023
Entity Ex Transition Period	false
Document Quarterly Report	true
Document Transition Report	false
Entity File Number	001-40905
Entity Incorporation State Country Code	E9
Entity Tax Identification Number	98-1587643
Entity Address Address Line 1	2 Burlington Woods Drive
Entity Address Address Line 2	Suite 100
Entity Address City Or Town	Burlington
Entity Address State Or Province	MA
Entity Address Postal Zip Code	01803
Entity Interactive Data Current	Yes
Entity Incorporation Date Of Incorporation	Mar. 05, 2021
City Area Code	601
Local Phone Number	321-1950
Ordinary Shares And Warrants Member
Document Information Line Items
Security 12b Title	Units, each consisting of one Class A Ordinary Share and one-half of one redeemable Warrant
Trading Symbol	TRIS.U
Security Exchange Name	NYSE
Class A Ordinary Shares [Member]
Document Information Line Items
Entity Common Stock Shares Outstanding		10,608,802
Security 12b Title	Class A Ordinary Shares, par value $0.0001 per share
Trading Symbol	TRIS
Security Exchange Name	NYSE
Warrants Exercisable And Ordinary Shares Member
Document Information Line Items
Security 12b Title	Warrants, each exercisable for one Class A Ordinary Share for $11.50 per share
Trading Symbol	TRIS.WS
Security Exchange Name	NYSE
Common Class B [Member]
Document Information Line Items
Entity Common Stock Shares Outstanding		5,750,000

Condensed Balance Sheets

Condensed Balance Sheets - USD ($)	Jun. 30, 2023	Dec. 31, 2022
CURRENT ASSETS:
Cash	$ 13,751	$ 587,546
Prepaid expenses	148,177	258,535
Total current assets	161,928	846,081
Investments held in Trust Account	241,463,580	235,933,496
TOTAL ASSETS	241,625,508	236,779,577
CURRENT LIABILITIES:
Accounts payable	34,975	99,514
Accrued expenses	189,676	198,580
Total current liabilities	224,651	298,094
LONGTERM LIABILITIES:
Derivative warrant liabilities	565,350	565,350
Deferred underwriting fee payable	0	10,350,000
Total long term liabilities	565,350	10,915,350
Total liabilities	790,001	11,213,444
Commitments and contingencies	0
Class A ordinary shares subject to possible redemption, 23,000,000 at $10.50 and $10.26 redemption value as of June 30, 2023 and December 31, 2022, respectively	241,461,089	235,931,005
Shareholders' deficit:
Preferred shares, $0.0001 par value; 1,000,000 shares authorized; none issued and outstanding	0	0
Additional paid-in capital	9,868,725	0
Accumulated deficit	(10,494,882)	(10,365,447)
Total shareholders' deficit	(625,582)	(10,364,872)
TOTAL LIABILITIES AND SHAREHOLDERS' DEFICIT	241,625,508	236,779,577
Common Class A [Member]
Shareholders' deficit:
Common stock, value	0	0
Common Class B [Member]
Shareholders' deficit:
Common stock, value	$ 575	$ 575

Condensed Balance Sheets (Paren

Condensed Balance Sheets (Parenthetical) - $ / shares	Jun. 30, 2023	Dec. 31, 2022
Preferred stock, par or stated value per share	$ 0.0001	$ 0.0001
Preferred stock, shares authorized	1,000,000	1,000,000
Preferred stock, shares issued	0	0
Preferred stock, shares outstanding	0	0
Temporary equity, redemption price per share	$ 10.50
Common Class A [Member]
Common stock, par or stated value per share	$ 0.0001	$ 0.0001
Common stock, shares authorized	90,000,000	90,000,000
Common stock, shares, issued	0	0
Common stock, shares, outstanding	0	0
Temporary equity shares outstanding	23,000,000	23,000,000
Temporary equity, redemption price per share	$ 10.50	$ 10.26
Common Class B [Member]
Common stock, par or stated value per share	$ 0.0001	$ 0.0001
Common stock, shares authorized	10,000,000	10,000,000
Common stock, shares, issued	5,750,000	5,750,000
Common stock, shares, outstanding	5,750,000	5,750,000

Condensed Statements of Operati

Condensed Statements of Operations (Unaudited) - USD ($)	3 Months Ended		6 Months Ended
	Jun. 30, 2023	Jun. 30, 2022	Jun. 30, 2023	Jun. 30, 2022
General and administrative expenses	$ (329,856)	$ (191,634)	$ (817,699)	$ (449,371)
Loss from operations	(329,856)	(191,634)	(817,699)	(449,371)
Other income
Interest income	688	0	2,473	0
Interest income - investments held in trust	2,939,754	153,796	5,530,083	159,650
Change in fair value of warrant liability	1,319,150	5,276,600	0	7,423,000
Forgiveness of deferred underwriting fee payable	481,275	0	481,275	0
Forgiveness of service administrative fee	204,516	0	204,516	0
Total other income	4,945,383	5,430,396	6,218,347	7,582,650
Net income	$ 4,615,527	$ 5,238,762	$ 5,400,648	$ 7,133,279
Class A Ordinary Shares [Member]
Other income
Basic and diluted weighted average shares outstanding	23,000,000	23,000,000	23,000,000	23,000,000
Basic and diluted net income per share	$ 0.16	$ 0.18	$ 0.19	$ 0.25
Class B Ordinary Shares [Member]
Other income
Basic and diluted weighted average shares outstanding	5,750,000	5,750,000	5,750,000	5,750,000
Basic and diluted net income per share	$ 0.16	$ 0.18	$ 0.19	$ 0.25

Condensed Statements of Changes

Condensed Statements of Changes Shareholders' Deficit (Unaudited) - USD ($)	Total	Class A Common Stock	Class B Common Stock	Additional Paid-in Capital	Retained Earnings
Balance, shares at Dec. 31, 2021			5,750,000
Balance, amount at Dec. 31, 2021	$ (18,492,400)	$ 0	$ 575	$ 0	$ (18,492,975)
Net income	1,894,517	0	$ 0	0	1,894,517
Balance, shares at Mar. 31, 2022			5,750,000
Balance, amount at Mar. 31, 2022	(16,597,883)	0	$ 575	0	(16,598,458)
Balance, shares at Dec. 31, 2021			5,750,000
Balance, amount at Dec. 31, 2021	(18,492,400)	0	$ 575	0	(18,492,975)
Net income	7,133,279
Balance, shares at Jun. 30, 2022			5,750,000
Balance, amount at Jun. 30, 2022	(11,518,407)	0	$ 575	0	(11,518,982)
Balance, shares at Mar. 31, 2022			5,750,000
Balance, amount at Mar. 31, 2022	(16,597,883)	0	$ 575	0	(16,598,458)
Net income	5,238,762	0	0	0	5,238,762
Remeasurement of Class A ordinary shares to redemption amount as of June 30, 2022	(159,286)	0	$ 0	0	(159,286)
Balance, shares at Jun. 30, 2022			5,750,000
Balance, amount at Jun. 30, 2022	(11,518,407)	0	$ 575	0	(11,518,982)
Balance, shares at Dec. 31, 2022			5,750,000
Balance, amount at Dec. 31, 2022	(10,364,872)	0	$ 575	0	(10,365,447)
Net income	785,121	0	0	0	785,121
Remeasurement of Class A ordinary shares to redemption amount amount as of March 31, 2023	(2,590,329)	0	$ 0	0	(2,590,329)
Balance, shares at Mar. 31, 2023			5,750,000
Balance, amount at Mar. 31, 2023	(12,170,080)	0	$ 575	0	(12,170,655)
Balance, shares at Dec. 31, 2022			5,750,000
Balance, amount at Dec. 31, 2022	(10,364,872)	0	$ 575	0	(10,365,447)
Net income	5,400,648
Balance, shares at Jun. 30, 2023			5,750,000
Balance, amount at Jun. 30, 2023	(625,582)	0	$ 575	9,868,725	(10,494,882)
Balance, shares at Mar. 31, 2023			5,750,000
Balance, amount at Mar. 31, 2023	(12,170,080)	0	$ 575	0	(12,170,655)
Net income	4,615,527	0	0	0	4,615,527
Remeasurement of Class A ordinary shares to redemption amount amount as of June 30, 2023	(2,939,754)	0	0	0	(2,939,754)
Forgiveness of deferred underwriting fee payable	9,868,725	0	$ 0	9,868,725	0
Balance, shares at Jun. 30, 2023			5,750,000
Balance, amount at Jun. 30, 2023	$ (625,582)	$ 0	$ 575	$ 9,868,725	$ (10,494,882)

Condensed Statements Of Cash Fl

Condensed Statements Of Cash Flows (Unaudited) - USD ($)	6 Months Ended
	Jun. 30, 2023	Jun. 30, 2022
CASH FLOWS FROM OPERATING ACTIVITIES:
Net income	$ 5,400,648	$ 7,133,279
Adjustments to reconcile net income to net cash used in operating activities:
Change in derivative warrant liabilities	0	(7,423,000)
Interest income earned on investments held in Trust Account	(5,530,083)	(159,286)
Forgiveness of deferred underwriting fee payable	(481,275)	0
Changes in operating assets and liabilities:
Prepaid expenses	110,358	128,578
Accounts payable	(64,539)	(107,018)
Accrued expenses	(8,904)	(43,359)
Net cash used in operating activities	(573,795)	(470,806)
NET DECREASE IN CASH	(573,795)	(470,806)
CASH BEGINNING OF PERIOD	587,546	1,231,992
CASH END OF PERIOD	13,751	761,186
SUPPLEMENTAL DISCLOSURE OF NON-CASH ACTIVITIES:
Forgiveness of deferred underwriting fee payable allocated to additional paid in capital	9,868,725	0
Remeasurement of Class A ordinary shares to redemption amount	$ 2,939,754	$ 159,286

Description of Organization and

Description of Organization and Business Operations and Liquidity	6 Months Ended
	Jun. 30, 2023
Description of Organization and Business Operations and Liquidity
Description of Organization and Business Operations and Liquidity	Note 1—Description of Organization and Business Operations and Liquidity Tristar Acquisition I Corp. (the “Company”) is a blank check company incorporated in the Cayman Islands on March 5, 2021. The Company was formed for the purpose of entering into a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses (a “Business Combination”). The Company is not limited to a particular industry or geographic region for purposes of consummating a Business Combination. The Company is an early stage and emerging growth company and, as such, the Company is subject to all of the risks associated with early stage and emerging growth companies. As of June 30, 2023 and December 31, 2022, the Company had not yet commenced any operations. All activity through June 30, 2023 relates to the Company’s formation and the initial public offering (“IPO” or “Initial Public Offering”) described below and since completion of the IPO, searching for a target with which to consummate a Business Combination. The Company will not generate any operating revenues until after the completion of its initial Business Combination, at the earliest. The Company will generate non-operating income in the form of interest income on cash and cash equivalents from the proceeds derived from the IPO. The Company has selected December 31 st The Company’s prior sponsor was Tristar Holdings I LLC, a Delaware limited liability company (the “Prior Sponsor”). On July 18, 2023, upon the consummation of the Sponsor Handover (as defined below), Navy Sail International Limited, a British Virgin Islands company (the “Sponsor”), became the new sponsor of the Company. Initial Public Offering The registration statement for the Company’s Initial Public Offering was declared effective on October 13, 2021. On October 18, 2021, the Company consummated the Initial Public Offering of 20,000,000 units (the “Units” and, with respect to the Class A ordinary shares included in the Units sold, the “Public Shares”), at $10.00 per Unit, generating total gross proceeds of $200,000,000, which is described in Note 3. On November 3, 2021, the underwriters exercised the over-allotment option (“over-allotment option”) and purchased an additional 3,000,000 Units, generating gross proceeds of $30 million, which is described in Note 3. Simultaneously with the closing of the Initial Public Offering and the over-allotment option, the Company consummated the sale of 7,345,000 warrants (the “Private Placement Warrants”) at a price of $1.00 per Private Placement Warrant in a private placement to the Prior Sponsor, generating gross proceeds of $7,345,000, which is described in Note 4. Transaction costs amounted to $25,995,754, consisting of $4,600,000 of underwriting fees, $10,350,000 of deferred underwriting fees, $12,546,764 for the fair value of the Founder Shares (as defined in Note 5) attributable to the anchor investors (see Note 5), and $1,003,989 of offering costs, partially offset by the reimbursement of $2,505,000 of offering expenses by the underwriters. The Company’s remaining cash after payment of the offering costs is held outside of the Company’s trust account (“Trust Account”) for working capital purposes. The Company will provide its public shareholders with the opportunity to redeem all or a portion of their Public Shares upon the completion of a Business Combination either (i) in connection with a shareholder meeting called to approve the Business Combination or (ii) by means of a tender offer. The decision as to whether the Company will seek shareholder approval of a Business Combination or conduct a tender offer will be made by the Company, in its sole discretion. The public shareholders will be entitled to redeem their Public Shares for a pro rata portion of the amount held in the Trust Account ($10.50 per share as of June 30, 2023), calculated as of two business days prior to the completion of a Business Combination, including any pro rata interest earned on the funds held in the Trust Account and not previously released to the Company to pay its tax obligations (less up to $100,000 of interest to pay dissolution expenses). There will be no redemption rights upon the completion of a Business Combination with respect to the Company’s warrants. The Class A ordinary shares are recorded at redemption value and classified as temporary equity upon the completion of the Initial Public Offering, in accordance with the Financial Accounting Standards Board’s (“FASB”) Accounting Standards Codification (“ASC”) Topic 480, Distinguishing Liabilities from Equity The Company will proceed with a Business Combination if a majority of the shares voted are voted in favor of the Business Combination. If a shareholder vote is not required under applicable law or stock exchange listing requirements and the Company does not decide to hold a shareholder vote for business or other reasons, the Company will, pursuant to its Amended and Restated Memorandum and Articles of Association as then in effect, conduct the redemptions pursuant to the tender offer rules of the Securities and Exchange Commission (“SEC”), and file tender offer documents containing substantially the same information as would be included in a proxy statement with the SEC prior to completing a Business Combination. If the Company seeks shareholder approval in connection with a Business Combination, the initial shareholders, Sponsor, anchor investors, and management team have agreed to vote any Founder Shares held by them, and any Public Shares purchased in or after the Initial Public Offering in favor of approving a Business Combination. Additionally, each public shareholder may elect to redeem their Public Shares irrespective of whether they vote for or against the proposed transaction or whether they were a public shareholder on the record date for the general meeting held to approve the proposed transaction. Notwithstanding the foregoing, if the Company seeks shareholder approval of a Business Combination and it does not conduct redemptions pursuant to the tender offer rules, the Amended and Restated Memorandum and Articles of Association provides that a public shareholder, together with any affiliate of such shareholder or any other person with whom such shareholder is acting in concert or as a “group” (as defined under Section 13 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”)), will be restricted from redeeming its shares with respect to more than an aggregate of 15% of the Public Shares without the Company’s prior written consent. The initial shareholders, the Sponsor, and our management team (as described in Note 5) have agreed to (i) waive their redemption rights with respect to any Founder Shares they hold in connection with the completion of an initial Business Combination, (ii) waive their redemption rights with respect to any Founder Shares and Public Shares they hold in connection with a shareholder vote to approve an amendment to the Amended and Restated Memorandum and Articles of Association to modify the substance or timing of the Company's obligation to redeem 100% of the Public Shares if the Company has not consummated an initial Business Combination by October 18, 2024 or with respect to any other material provisions relating to shareholders’ rights or pre-initial Business Combination activity and (iii) waive their rights to liquidating distributions from the Trust Account with respect to any Founder Shares they hold if the Company fails to complete an initial Business Combination by October 18, 2024. However, if the initial shareholders or the Sponsor acquire Public Shares in or after the Initial Public Offering, such Public Shares will be entitled to liquidating distributions from the Trust Account if the Company fails to complete a Business Combination within the Combination Period (as defined below). The Company will have until October 18, 2023, or up until October 18, 2024 if it utilizes the full Extension(the “Combination Period”) to complete a Business Combination. If the Company is unable to complete a Business Combination within the Combination Period, the Company will (i) cease all operations except for the purpose of winding up, (ii) as promptly as reasonably possible but not more than ten business days thereafter, redeem the Public Shares, at a per-share price, payable in cash, equal to the aggregate amount then on deposit in the Trust Account, including interest earned on the funds held in the Trust Account (which interest shall be net of taxes payable and up to $100,000 of interest to pay dissolution expenses), divided by the number of then outstanding Public Shares, which redemption will completely extinguish public shareholders’ rights as shareholders (including the right to receive further liquidating distributions, if any), and (iii) as promptly as reasonably possible following such redemption, subject to the approval of the Company's remaining shareholders and board of directors (the “Board”), liquidate and dissolve, subject, in each case, to the Company's obligations under Cayman Islands law to provide for claims of creditors and the requirements of other applicable law. The underwriters have agreed to waive their rights to their deferred underwriting commission (see Note 6) held in the Trust Account in the event the Company does not complete a Business Combination within the Combination Period and, in such event, such amounts will be included with the other funds held in the Trust Account that will be available to fund the redemption of the Public Shares. In the event of such distribution, it is possible that the per share value of the assets remaining available for distribution will be less than the Initial Public Offering price per Unit ($10.00). In order to protect the amounts held in the Trust Account, the Prior Sponsor has agreed to be liable to the Company if and to the extent any claims by a third party for services rendered or products sold to the Company, or a prospective target business with which the Company has discussed entering into a transaction agreement, reduce the amount of funds in the Trust Account to below (1) $10.10 per Public Share or (2) the actual amount per Public Share held in the Trust Account as of the date of the liquidation of the Trust Account if less than $10.10 per Public Share due to reductions in the value of the trust assets, in each case net of the interest that may be withdrawn to pay the Company’s tax obligations, provided that such liability will not apply to any claims by a third-party or prospective target business that executed a waiver of any and all rights to seek access to the Trust Account (whether or not such waiver is enforceable) nor will it apply to any claims under the Company's indemnity of the underwriters of the Initial Public Offering against certain liabilities, including liabilities under the Securities Act of 1933, as amended (the “Securities Act”). Moreover, in the event that an executed waiver is deemed to be unenforceable against a third party, the Sponsor will not be responsible to the extent of any liability for such third-party claims. The Company will seek to reduce the possibility that the Sponsor will have to indemnify the Trust Account due to claims of creditors by endeavoring to have all vendors, service providers (other than the Company's independent registered public accounting firm), prospective target businesses or other entities with which the Company does business, execute agreements with the Company waiving any right, title, interest or claim of any kind in or to monies held in the Trust Account. On March 1, 2023, the Company entered into a non-binding letter of intent that sets forth preliminary terms and conditions of a potential Business Combination with a privately held company that the Company believe substantially meets our criteria and guidelines with which we have had discussions over an extended period of time. On June 12, 2023, the Company sent a written notice terminating the letter of intent. Extension On July 18, 2023, the Company held an extraordinary general meeting of shareholders (the “EGM”). At the EGM, the Company’s shareholders approved, among other things, an amendment to the Amended and Restated Memorandum and Articles of Association (the “Charter Amendment”) to (i) extend the date by which it has to complete a Business Combination (the “Termination Date”) from July 18, 2023 to October 18, 2023, and without another shareholder vote, to further extend the Termination Date for an additional one (1) month as needed, on a month-to-month basis, up to twelve (12) times, until October 18, 2024 (the “Extension”), and (ii) remove the limitation that the Company may not redeem Public Shares to the extent that such redemption would result in the Company having net tangible assets (as determined in accordance with Rule 3a51-1(g)(1) of the Exchange Act), of less than $5,000,001 (the “Redemption Limitation”) in order to allow the Company to redeem Public Shares irrespective of whether such redemption would exceed the Redemption Limitation. In connection with the Charter Amendment, shareholders holding 12,391,198 Public Shares exercised their right to redeem such shares for a pro rata portion of the funds in the Trust Account. As a result, $130,320,650 (approximately $10.52 per share) was removed from the Trust Account to pay such holders. Following redemptions, the Company had 10,608,802 Public Shares outstanding. Sponsor Handover On July 18, 2023, the Company entered into a securities purchase agreement (the “Securities Purchase Agreement”) with the Company’s Prior Sponsor and the Sponsor and its designees (the “Purchaser”), whereby the Prior Sponsor agreed to transfer to the Purchaser 3,046,634 of the Company’s Class B ordinary shares and 4,957,875 Private Placement Warrants purchased at the time of the Company’s IPO. In addition, all other holders of Class B ordinary shares transferred an aggregate of 1,380,866 of their Class B ordinary shares to Chunyi (Charlie) Hao pursuant to share transfer agreements executed by each respective holder on July 18, 2023 (the “Share Transfer Agreements”). The transfer of all Class B ordinary shares is referred to as the “Transfer.” The Transfer, all agreements executed in connection with the Transfer (including the transactions contemplated therein) and the Management Change (as defined below) are referred to as the “Sponsor Handover.” The Sponsor Handover closed on July 18, 2023 (the “Closing”). In connection with the Sponsor Handover, the Company, its officers and directors, the Sponsor and the Purchaser entered into additional agreements whereby: (a) the Purchaser and its designees signed a joinder agreement (the “Joinder Agreement”) to become a party to the Letter Agreement (the “Letter Agreement”) and the Registration Rights Agreement (“Registration Rights Agreement”), both dated October 13, 2021 and entered into in connection with the IPO, among the Company, the Sponsor and certain equityholders of the Company; and (b) the Letter Agreement was amended by the parties thereto to allow for the Transfer (the “Letter Agreement Amendment”). In addition, at the Closing, the Company’s IPO underwriters waived their respective entitlement to the payment of any deferred underwriting fees to be paid under the terms of Section 2(c) and Section 5(bb) of the Underwriting Agreement dated October 13, 2021 (the “Underwriting Agreement”). As part of the Sponsor Handover, the Company introduced a change in management (the “ Management Change Waiting Period In connection with the Closing, on July 18, 2023, the Purchaser caused $375,000 to be deposited into the Trust Account to support the first three months of the Extension from July 18, 2023 to October 18, 2023. The Purchaser has agreed to deposit into the Trust Account an additional $125,000 for each successive month, or portion thereof, that is needed by the Company to complete an initial Business Combination until the end of the Combination Period. On July 18, 2023, the Company issued an unsecured promissory note (the “July 2023 Extension Note”) in an amount of $375,000, to Chunyi (Charlie) Hao, for having depositing into the Trust Account $375,000 in order to support the first three months of the Extension from July 18, 2023 to October 18, 2023. The July 2023 Extension Note does not bear interest and will be due and payable by the Maker on the earlier (a) the date that the Company consummates an initial Business Combination and (b) the date of the liquidation of the Company. Liquidity, Capital Resources and Going Concern As of June 30, 2023 and December 31, 2022, the Company had cash outside the Trust Account of $13,751 and $587,546 available for working capital needs respectively. All remaining cash held in the Trust Account are generally unavailable for the Company’s use, prior to an initial Business Combination and is restricted for use either in a Business Combination or to redeem ordinary shares. As of June 30, 2023 and December 31, 2022, none of the amount in the Trust Account was available to be withdrawn as described above. Until consummation of its Business Combination, the Company will be using the funds not held in the Trust Account, and any additional Working Capital Loans (as defined in Note 5) for identifying and evaluating prospective acquisition candidates, performing business due diligence on prospective target businesses, traveling to and from the offices, plants or similar locations of prospective target businesses, reviewing corporate documents and material agreements of prospective target businesses, selecting the target business to acquire and structuring, negotiating and consummating the Business Combination. In connection with the Company’s assessment of going concern considerations in accordance with FASB ASU 2014-15, “Disclosures of Uncertainties about an Entity’s Ability to Continue as a Going Concern,” the Company has until October 18, 2024 to consummate a Business Combination. It is uncertain that the Company will be able to consummate a Business Combination by this time. If a Business Combination is not consummated by this date and a further extension is not approved by the Company’s shareholders, there will be a mandatory liquidation and subsequent dissolution of the Company. Management has determined that the mandatory liquidation, should a Business Combination not occur within the Combination Period and a further extension is not approved by the Company’s shareholders, and potential subsequent dissolution raises substantial doubt about the Company’s ability to continue as a going concern. No adjustments have been made to the carrying amounts of assets or liabilities should the Company be required to liquidate after October 18, 2024. Additionally, the Company may need to raise additional capital in order to operate our business prior to our initial Business Combination through loans or additional investments. The Company’s officers, directors, Sponsor or affiliate of our Sponsor may, but are not obligated to loan the Company funds to meet working capital needs. Accordingly, the Company may not be able to obtain additional financing. If the Company is unable to raise additional capital, it may be required to take additional measures to conserve liquidity, which could include, but not necessarily be limited to, curtailing operations, suspending the pursuit of a potential transaction, and reducing overhead expenses. The Company cannot provide any assurance that new financing will be available to it on commercially acceptable terms, if at all. These conditions raise substantial doubt about the Company’s ability to continue as a going concern. No adjustments have been made relating to the recovery of the recorded assets or the classification of the liabilities that might be necessary should the Company be unable to continue as a going concern. Risks and Uncertainties Management continues to evaluate the impact of the COVID-19 pandemic and has concluded that while it is reasonably possible that the virus could have a negative effect on the Company’s financial position, results of its operations, and/or search for a target company, the specific impact is not readily determinable as of the date of the financial statements. The financial statements do not include any adjustments that might result from the outcome of this uncertainty. In February 2022, the Russian Federation and Belarus commenced a military action with the country of Ukraine. As a result of this action, various nations, including the United States, have instituted economic sanctions against the Russian Federation and Belarus. Further, the impact of this action and related sanctions on the world economy is not determinable as of the date of these financial statements. The specific impact on the Company’s financial condition, results of operations, and cash flows is also not determinable as of the date of these financial statements.

Significant Accounting Policies

Significant Accounting Policies	6 Months Ended
	Jun. 30, 2023
Significant Accounting Policies
Significant Accounting Policies	Note 2—Significant Accounting Policies Basis of Presentation The accompanying financial statement is presented in conformity with accounting principles generally accepted in the United States of America (“GAAP”) and pursuant to the rules and regulations of the SEC, and reflect all adjustments, consisting only of normal recurring adjustments, which are, in the opinion of management, necessary for the fair presentation of the financial position as of June 30, 2023 and the results of operations and cash flows for the period presented and should be read in conjunction with the Company’s Annual Report on Form 10-K for the year ended December 31, 2022. The financial information as of December 31, 2022 is derived from the audited financial statements presented in the Company’s Annual Report on Form 10-K for the year ended December 31, 2022. The interim results for the three and six months ended June 30, 2023 are not necessarily indicative of the results to be expected for the year ending December 31, 2023 or for any future periods. Emerging Growth Company The Company is an “emerging growth company,” as defined in Section 2(a) of the Securities Act, as modified by the Jumpstart our Business Startups Act of 2012 (the “JOBS Act”), and it may take advantage of certain exemptions from various reporting requirements that are applicable to other public companies that are not emerging growth companies including, but not limited to, not being required to comply with the auditor attestation requirements of Section 404 of the Sarbanes-Oxley Act, reduced disclosure obligations regarding executive compensation in its periodic reports and proxy statements, and exemptions from the requirements of holding a nonbinding advisory vote on executive compensation and shareholder approval of any golden parachute payments not previously approved. Further, section 102(b)(1) of the JOBS Act exempts emerging growth companies from being required to comply with new or revised financial accounting standards until private companies (that is, those that have not had a Securities Act registration statement declared effective or do not have a class of securities registered under the Exchange Act) are required to comply with the new or revised financial accounting standards. The JOBS Act provides that an emerging growth company can elect to opt out of the extended transition period and comply with the requirements that apply to non-emerging growth companies but any such election to opt out is irrevocable. The Company has elected not to opt out of such extended transition period which means that when a standard is issued or revised and it has different application dates for public or private companies, the Company, as an emerging growth company, can adopt the new or revised standard at the time private companies adopt the new or revised standard. This may make comparison of the Company’s financial statements with another public company which is neither an emerging growth company nor an emerging growth company which has opted out of using the extended transition period difficult or impossible because of the potential differences in accounting standards used. Use of Estimates The preparation of the financial statements in conformity with U.S. GAAP requires the Company’s management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of expenses during the reporting period. Making estimates requires management to exercise significant judgment. It is at least reasonably possible that the estimate of the effect of a condition, situation or set of circumstances that existed at the date of the financial statements, which management considered in formulating its estimate, could change in the near term due to one or more future confirming events. Accordingly, the actual results could differ from those estimates. Cash and Cash Equivalents The Company considers all short-term investments with an original maturity of three months or less when purchased to be cash equivalents. The Company did not have any cash equivalents as of June 30, 2023 and December 31, 2022. Investments Held in Trust Account As of June 30, 2023 and December 31, 2022, the assets held in Trust Account were held in money market funds, which invest in U.S. Treasury securities. The Company’s portfolio of investments held in the Trust Account is comprised of U.S. government securities, within the meaning set forth in Section 2(a)(16) of the Investment Company Act, with a maturity of 185 days or less, or investments in money market funds that invest in U.S. government securities, or a combination thereof. The Company classifies its U.S. Treasury securities as trading securities in accordance with FASB ASC 320 “Investments—Debt and Equity Securities.” Class A Ordinary Shares Subject to Possible Redemption The Company accounts for its ordinary shares subject to possible redemption in accordance with the guidance in ASC 480. Ordinary shares subject to mandatory redemption are classified as a liability instrument and are measured at fair value. Conditionally redeemable ordinary shares (including ordinary shares that feature redemption rights that are either within the control of the holder or subject to redemption upon the occurrence of uncertain events not solely within the Company’s control) are classified as temporary equity. At all other times, ordinary shares are classified as shareholders’ equity. The Company’s ordinary shares feature certain redemption rights that are considered to be outside of the Company’s control and subject to the occurrence of uncertain future events. The Company recognizes changes in redemption value immediately as they occur and adjusts the carrying value of redeemable Class A ordinary shares to equal the redemption value at the end of each reporting period. Increases or decreases in the carrying amount of redeemable Class A ordinary shares are affected by charges against additional paid-in capital and accumulated deficit. As of June 30, 2023 and December 31, 2022, 23,000,000 Class A ordinary shares subject to possible redemption are presented at redemption value as temporary equity, outside of the shareholders’ deficit section of the Company’s balance sheet. Offering Costs associated with the Initial Public Offering The Company complies with the requirements of ASC 340-10-S99-1 and SEC Staff Accounting Bulletin Topic 5A - Expenses of Offering Income Taxes The Company accounts for income taxes under ASC 740, Income Taxes ASC 740 also clarifies the accounting for uncertainty in income taxes recognized in an enterprise’s financial statements and prescribes a recognition threshold and measurement process for financial statement recognition and measurement of a tax position taken or expected to be taken in a tax return. For those benefits to be recognized, a tax position must be more-likely-than-not to be sustained upon examination by taxing authorities. ASC 740 also provides guidance on derecognition, classification, interest and penalties, accounting in interim period, disclosure and transition. Based on the Company’s evaluation, it has been concluded that there are no significant uncertain tax positions requiring recognition in the Company’s financial statements. Since the Company was incorporated on March 5, 2021, the evaluation was performed for the 2022 and 2021 tax years which will be the only periods subject to examination. The Company recognizes accrued interest and penalties related to unrecognized tax benefits as income tax expense. There were no unrecognized tax benefits and no amounts accrued for interest and penalties as of June 30, 2023 and December 31, 2022. The Company is currently not aware of any issues under review that could result in significant payments, accruals or material deviation from its position. There are no taxes in the Cayman Islands and accordingly income taxes are not levied on the Company. Consequently, income taxes are not reflected in the Company’s financial statements. Share-based Compensation The Company adopted ASC Topic 718, Compensation—Stock Compensation, guidance to account for its share-based compensation. It defines a fair value-based method of accounting for an employee share option or similar equity instrument. The Company recognizes all forms of share-based payments, including share option grants, warrants and restricted share grants, at their fair value on the grant date, which are based on the estimated number of awards that are ultimately expected to vest. Share-based payments, excluding restricted shares, are valued using a Black-Scholes option pricing model. Grants of share-based payment awards issued to nonemployees for services rendered have been recorded at the fair value of the share based payment, which is the more readily determinable value. The grants are amortized on a straight-line basis over the requisite service periods, which is generally the vesting period. If an award is granted, but vesting does not occur, any previously recognized compensation cost is reversed in the period related to the termination of service. Share-based compensation expenses are included in costs and operating expenses depending on the nature of the services provided in the statements of operations. Concentration of Credit Risk Financial instruments that potentially subject the Company to concentrations of credit risk consist of a cash account in a financial institution, which, at times, may exceed the Federal Depository Insurance Coverage of $250,000. The Company has not experienced losses on this account and management believes the Company is not exposed to significant risks on such account. Derivative Financial Instruments The Company evaluates its financial instruments to determine if such instruments are derivatives or contain features that qualify as embedded derivatives in accordance with ASC Topic 815, “Derivatives and Hedging.” Derivative instruments are initially recorded at fair value on the grant date and re-valued at each reporting date, with changes in the fair value reported in the statements of operations. Derivative assets and liabilities are classified in the balance sheet as current or non-current based on whether or not net-cash settlement or conversion of the instrument could be required within 12 months of the balance sheet date. Warrant Liabilities The Company evaluated the Public Warrants and Private Placement Warrants (collectively, “Warrants”), in accordance with ASC 815-40, “Derivatives and Hedging -- Contracts in Entity’s Own Equity,” and concluded that a provision in the Warrant Agreement related to certain tender or exchange offers precludes the Warrants from being accounted for as components of equity. As the Warrants meet the definition of a derivative as contemplated in ASC 815, the Warrants are recorded as derivative liabilities on the balance sheet and measured at fair value at inception (on the date of the IPO) and at each reporting date in accordance with ASC 820, “Fair Value Measurement,” with changes in fair value recognized in the statement of operations in the period of change. Fair Value of Financial Instruments ASC 820 establishes a fair value hierarchy that prioritizes and ranks the level of observability of inputs used to measure investments at fair value. The observability of inputs is impacted by a number of factors, including the type of investment, characteristics specific to the investment, market conditions and other factors. The hierarchy gives the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (Level 1 measurements) and the lowest priority to unobservable inputs (Level 3 measurements). Investments with readily available quoted prices or for which fair value can be measured from quoted prices in active markets will typically have a higher degree of input observability and a lesser degree of judgment applied in determining fair value. The carrying amounts reflected in the balance sheet for cash, prepaid expenses, due from related party, investments held in Trust Account, accounts payable, and accrued offering costs and expenses approximate fair value due to their short-term nature. The three levels of the fair value hierarchy under ASC 820 are as follows: Level 1—Quoted prices (unadjusted) in active markets for identical investments at the measurement date are used. Level 2—Pricing inputs are other than quoted prices included within Level 1 that are observable for the investment, either directly or indirectly. Level 2 pricing inputs include quoted prices for similar investments in active markets, quoted prices for identical or similar investments in markets that are not active, inputs other than quoted prices that are observable for the investment, and inputs that are derived principally from or corroborated by observable market data by correlation or other means. Level 3—Pricing inputs are unobservable and include situations where there is little, if any, market activity for the investment. The inputs used in determination of fair value require significant judgment and estimation. In some cases, the inputs used to measure fair value might fall within different levels of the fair value hierarchy. In such cases, the level in the fair value hierarchy within which the investment is categorized in its entirety is determined based on the lowest level input that is significant to the investment. Assessing the significance of a particular input to the valuation of an investment in its entirety requires judgment and considers factors specific to the investment. The categorization of an investment within the hierarchy is based upon the pricing transparency of the investment and does not necessarily correspond to the perceived risk of that investment. See Note 9 for additional information on assets and liabilities measured at fair value. Net Income Per Ordinary Share The Company applies the two-class method in calculating net income per ordinary share. The contractual formula utilized to calculate the redemption amount approximates fair value. The Class feature to redeem at fair value means that there is effectively only one class of ordinary share. Changes in fair value are not considered a dividend of the purposes of the numerator in the earnings per share calculation. Net income per ordinary share is computed by dividing the pro rata net income between the Class A ordinary share and the Class B ordinary share by the weighted average number of ordinary shares outstanding. The calculation of diluted income per ordinary share does not consider the effect of the warrants and rights issued in connection with the Public Offering since the exercise of the warrants and rights are contingent upon the occurrence of future events and the inclusion of such warrants would be anti-dilutive. The warrants and rights are exercisable for 18,845,000 shares of Class A ordinary share in the aggregate. For the three months ended June 30, 2023 For the three months ended June 30, 2022 Ordinary shares subject to possible redemption Numerator: Earnings allocable to Redeemable Class A ordinary shares Net income allocable to Class A ordinary shares subject to possible redemption $ 3,692,422 $ 4,191,010 Denominator: Redeemable Class A ordinary shares, Basic and diluted weighted average shares outstanding 23,000,000 23,000,000 Basic and diluted net income per share, Redeemable Class A ordinary share $ 0.16 $ 0.18 Non-redeemable ordinary shares Numerator: Net income allocable to Class B ordinary shares not subject to redemption Net income allocable to Class B ordinary shares not subject to redemption $ 923,105 $ 1,047,752 Denominator: Weighted Average non-redeemable Class B ordinary shares Basic and diluted weighted average shares outstanding 5,750,000 5,750,000 Basic and diluted net income per share $ 0.16 $ 0.18 For the six months ended June 30, 2023 For the six months ended June 30, 2022 Ordinary shares subject to possible redemption Numerator: Earnings allocable to Redeemable Class A ordinary shares Net income allocable to Class A ordinary shares subject to possible redemption $ 4,320,518 $ 5,706,623 Denominator: Redeemable Class A ordinary shares, Basic and diluted weighted average shares outstanding 23,000,000 23,000,000 Basic and diluted net income per share, Redeemable Class A ordinary share $ 0.19 $ 0.25 Non-redeemable ordinary shares Numerator: Net income allocable to Class B ordinary shares not subject to redemption Net income allocable to Class B ordinary shares not subject to redemption $ 1,080,130 $ 1,426,656 Denominator: Weighted Average non-redeemable Class B ordinary shares Basic and diluted weighted average shares outstanding 5,750,000 5,750,000 Basic and diluted net income per share $ 0.19 $ 0.25 Management does not believe that any other recently issued, but not yet effective, accounting standards, if currently adopted, would have a material effect on the Company’s financial statements.

Initial Public Offering

Initial Public Offering	6 Months Ended
	Jun. 30, 2023
Initial Public Offering
Initial Public Offering	Note 3—Initial Public Offering Pursuant to the Initial Public Offering, the Company sold 20,000,000 Units, at a purchase price of $10.00 per Unit. Each Unit consists of one Class A ordinary share and one-half of one redeemable warrant (“Public Warrant”). Each Public Warrant entitles the holder to purchase one Class A ordinary share at an exercise price of $11.50 per whole share (see Note 7). The Company granted the underwriters an option, exercisable for 45 days from the date of the prospectus, October 13, 2021, to purchase up to 3,000,000 additional Units. The underwriters exercised the over-allotment option on November 3, 2021 by purchasing 3,000,000 Units at a purchase price of $10.00 per Unit. Each Unit consists of one Class A ordinary share and one-half of one redeemable warrant (“Public Warrant”). Each Public Warrant entitles the holder to purchase one Class A ordinary share at an exercise price of $11.50 per whole share (see Note 7).

Private Placement

Private Placement	6 Months Ended
	Jun. 30, 2023
Private Placement
Private Placement	Note 4—Private Placement Simultaneously with the closing of the Initial Public Offering, the Prior Sponsor purchased an aggregate of 6,775,000 Private Placement Warrants at a price of $1.00 per Private Placement Warrant ($6,775,000 in the aggregate). Each Private Placement Warrant is exercisable to purchase one Class A ordinary share at a price of $11.50 per share. The proceeds from the sale of the Private Placement Warrants were added to the net proceeds from the Initial Public Offering held in the Trust Account. If the Company does not complete a Business Combination within the Combination Period, the proceeds from the sale of the Private Placement Warrants will be used to fund the redemption of the Public Shares (subject to the requirements of applicable law) and the Private Placement Warrants will expire worthless. On November 3, 2021, pursuant to the underwriters exercising the additional Units (see Note 4), the Prior Sponsor purchased an additional 570,000 Private Placement Warrants at a price of $1.00. On July 18, 2023, in connection with the Sponsor Handover, the Prior Sponsor transferred 4,957,875 Private Placement Warrants to a designee of the New Sponsor, pursuant to the Share Purchase Agreement.

Related Party Transactions

Related Party Transactions	6 Months Ended
	Jun. 30, 2023
Related Party Transactions
Related Party Transactions	Note 5—Related Party Transactions Founder Shares On March 15, 2021, the Prior Sponsor subscribed to purchase 7,187,500 Class B ordinary shares of the Company, par value $0.0001 per share (the “Founder Shares”), and fully paid for those shares on March 19, 2021. In August 2021, the Prior Sponsor forfeited 1,437,500 Founder Shares, resulting in a decrease in the total number of Founder Shares from 7,187,500 to 5,750,000. All shares and associated amounts have been retroactively restated to reflect the share forfeiture. In March 2021, the Prior Sponsor transferred 50,000 Founder Shares (25,000 shares each) to the then-chief financial officer and then-chief operating officer at their original purchase price. In November 2021, the Prior Sponsor transferred a total of 150,000 Founder Shares to six director nominees (25,000 shares to each director nominee) for no consideration. The Company estimated the fair value of the Founder Shares attributable to the director nominees to be $1,116,000 or $7.44 per share. The transfer of Founder Shares is in the scope of FASB ASC Topic 718 “Compensation Stock Compensation” (“ASC 718”). Under ASC 718, stock-based compensation associated with equity-classified awards is measured at fair value upon the grant date and expensed when earned. Shares granted to the directors, chief financial officer and chief operating officer are forfeited if their status as director or officer is terminated for any reason prior to the date of the initial Business Combination, and as such, there has been no stock-based compensation expense recognized in the accompanying financial statements. The initial shareholders have agreed that, subject to certain limited exceptions, the Founder Shares will not be transferred, assigned, or sold until the earlier of (i) one year after the completion of a Business Combination or (ii) subsequent to an initial Business Combination, (x) if the closing price of Class A ordinary shares equals or exceeds $12.00 per share (as adjusted for share subdivisions, share capitalizations, reorganizations, recapitalizations and the like) for any 20 trading days within any 30-trading day period commencing at least 150 days after an initial Business Combination, or (y) the date on which the Company completes a liquidation, merger, share exchange or other similar transaction that results in all of the public shareholders having the right to exchange their ordinary shares for cash, securities or other property. A total of eleven anchor investors each purchased an allocation of Units as determined by the underwriters, in the Initial Public Offering at the offering price of $10.00 per unit. Pursuant to such Units, the anchor investors have not been granted any shareholder or other rights in addition to those afforded to the Company’s other public shareholders. Further, the anchor investors are not required to (i) hold any Units, Class A ordinary shares or warrants they may purchase in the Initial Public Offering or thereafter for any amount of time, (ii) vote any Class A ordinary shares they may own at the applicable time in favor of the Business Combination or (iii) refrain from exercising their right to redeem their Public Shares at the time of the Business Combination. The anchor investors will have the same rights to the funds held in the Trust Account with respect to the Class A ordinary shares underlying the Units purchased in the Initial Public Offering as the rights afforded to the Company’s other public shareholders. Each anchor investor has entered into separate investment agreements with the Company and the Prior Sponsor pursuant to which each anchor investor agreed to purchase a specified number of Founder Shares. One anchor investor purchased 333,333 Founder Shares at a purchase price of $3 per share. In addition, the Prior Sponsor sold to the other ten anchor investors an aggregate of 1,585,000 of Founder Shares at a purchase price of $0.01 per share. Pursuant to the investment agreements, the anchor investors have agreed to (a) vote any Founder Shares held by them in favor of the Business Combination and (b) subject any Founder Shares held by them to the same lock-up restrictions as the Founder Shares held by the Prior Sponsor. The Company estimated the fair value of the Founder Shares attributable to the anchor investors to be $13,562,614 or $7.07 per share. The excess of the fair value of the Founder Shares sold over the purchase price of $1,015,850 was determined to be an offering cost in accordance with Staff Accounting Bulletin Topic 5A. Accordingly, the offering cost will be allocated to the separable financial instruments issued in the Initial Public Offering based on a relative fair value basis, compared to total proceeds received. Offering costs allocated to derivative warrant liabilities will be expensed immediately in the statement of operations. Offering costs allocated to the Public Shares will be charged to shareholders’ deficit upon the completion of the Initial Public Offering. Administrative Support Agreement In connection with the IPO, the Company entered into an agreement with the Prior Sponsor, to pay a total of $10,000 per month for office space, secretarial and administrative services. Upon the completion of an initial Business Combination or liquidation, the Company will cease paying these monthly fees. As of June 30, 2023 and December 31, 2022 the Company owed the Prior Sponsor $204,516 and $144,516 respectively, and is included in accrued expenses on the balance sheets; However, on June 30, 2023, in connection with the Sponsor Handover, the agreement with the Prior Sponsor was terminated and the outstanding amount was cancelled. The Company classified this gain on extinguishment in other income in the statements of operations. Related Party Loans In order to fund working capital deficiencies or finance transaction costs in connection with a Business Combination, the Sponsor or an affiliate of the Sponsor, or certain of the Company’s officers and directors may, but are not obligated to, loan the Company funds as may be required (“Working Capital Loans”). If the Company completes a Business Combination, the Company may repay the Working Capital Loans out of the proceeds of the Trust Account released to the Company. Otherwise, the Working Capital Loans could be repaid only out of funds held outside the Trust Account. In the event that a Business Combination does not close, the Company may use a portion of proceeds held outside the Trust Account to repay the Working Capital Loans but no proceeds held in the Trust Account would be used to repay the Working Capital Loans. The Working Capital Loans would either be repaid upon consummation of a Business Combination or, at the lender’s discretion, up to $1,500,000 of such Working Capital Loans may be convertible into warrants of the post Business Combination entity at a price of $1.00 per warrant. The warrants would be identical to the Private Placement Warrants. Except for the foregoing, the terms of such Working Capital Loans, if any, have not been determined and no written agreements exist with respect to such loans. On June 12, 2023, we issued an unsecured promissory note to the Prior Sponsor, whereby the Prior Sponsor agreed to loan up to $250,000 to us for working capital needs (the “Prior Sponsor Working Capital Loan”). The Prior Sponsor has the option to convert all or any portion of the Prior Sponsor Working Capital Loan into Private Placement Warrants at a price of $1.00 per Private Placement Warrant. The Prior Sponsor Working Capital Loan accrues no interest on the unpaid principal balance. The Prior Sponsor Working Capital Loan is due demand by the Prior Sponsor. Drawdowns may be requested until December 31, 2023. As of June 30, 2023, we had not had any drawdowns under the Prior Sponsor Working Capital Loan. Subsequent to June 30, 2023, the Company has made drawdowns totaling $158,968.

Commitments and Contingencies

Commitments and Contingencies	6 Months Ended
	Jun. 30, 2023
Commitments and Contingencies
Commitments and Contingencies	Note 6—Commitments and Contingencies Registration Rights Agreement The holders of the Founder Shares, Private Placement Warrants and warrants that may be issued upon conversion of Working Capital Loans (and any Class A ordinary shares issuable upon the exercise of the Private Placement Warrants and warrants issued upon conversion of the Working Capital Loans) are entitled to registration rights pursuant to a registration rights agreement to be signed prior to or on the effective date of the Initial Public Offering. The holders of these securities are entitled to make up to three demands, excluding short form demands, that the Company register such securities. In addition, the holders have certain “piggy-back” registration rights with respect to registration statements filed subsequent to consummation of a Business Combination. The Company bears the expenses incurred in connection with the filing of any such registration statements. Underwriting Agreement The Company paid an underwriting discount of $0.20 per Public Unit Offering price to the underwriters at the closing of the IPO and over-allotment option. The underwriting discount was paid in cash. In addition, the Company agreed to pay deferred underwriting commissions of $0.45 per Public Unit, or $10,350,000 in the aggregate. The deferred underwriting commission would become payable to the underwriters from the amount held in the Trust Account solely in the event that the Company completes a Business Combination, subject to the terms of the underwriting agreement, including the performance of services specified therein. On June 23, 2023, the underwriters agreed to waive there entitlement to the deferred underwriting commission of $10,350,000 to which it became entitled upon completion of the Company’s IPO. As a result, the Company derecognized the entire deferred underwriting fee payable of $10,350,000 and recorded $9,868,725 of the forgiveness of the deferred underwriting fee allocated to Public Shares to additional paid-in capital and the remaining balance of $481,275 was a gain from extinguishment of liability allocated to warrant liabilities. Forward Purchase Agreements On June 21, 2021 and July 26, 2021, respectively, the Company entered into forward purchase agreements pursuant to which one anchor investor and one institutional accredited investor that are not affiliated with the Prior Sponsor or any member of the Company’s management, have subscribed to purchase from the Company an aggregate of 4,500,000 Class A ordinary shares at a price of $10.00 per share as described in the forward purchase agreements, each in a private placement that will close immediately prior to the closing of our initial Business Combination. The terms of the forward purchase shares will generally be identical to the Class A ordinary shares included in the Units being sold in this offering, except that they will have registration rights and rights of first refusal with respect to any Business Combination financing, as described in the forward purchase agreements. One of the forward purchase investors may elect, in its sole discretion, to purchase convertible debt securities or non-convertible debt instruments in lieu of the forward purchase shares, or a combination thereof, for an aggregate purchase price of up to $25,000,000. Investment Banking Services In February 2023, the Company entered into an agreement with a third party investment banking company to provide certain investment banking services in connection with a potential Business Combination of a privately held company as described in Note 1 and a possible private placement by the Company to one or more potential investors of securities of the Company in connection with the potential Business Combination. The investment banking company as part of the agreement, may be entitled to success fees in the event that the Company finalizes a Business Combination. If a Business Combination is consummated, the investment banking company would be entitled to the following: - The Company will pay or cause to be paid to the investment banking company a success fee equal to $10,000,000 - In the event that a possible private placement offering is consummated, the Company will pay or cause to be paid a success fee equal to 3.5% of the total amount of cash and the fair market value of the other property paid to the Company, any of their security holders or any of their directors or executive officers in connection with the private placement offering. A credit of 50% of the fee payable to the third party investment banking company for a private placement offering shall reduce the success fee payable above. The investment banking company shall be entitled to a portion of such success fees as noted above, as determined by the Company, provided, however that in no event shall the investment banking company’s portion of such success fees be less than 50% of the total success fees. The Company also agrees to reimburse the investment banking company for all reasonable out-of-pocket expenses, not to exceed $525,000, regardless of the consummation of a Business Combination. As of June 30, 2023 the Company has accrued unbilled reimbursable costs of $98,089. In July 2023, the Company terminated the agreement with the third party investment banking company for the provision of certain investment banking services in connection with a potential Business Combination (which included waiver of all potential fees and rights thereunder by the third party investment banking company, excluding the above unbilled reimbursable costs noted above).

Warrant Liability

Warrant Liability	6 Months Ended
	Jun. 30, 2023
Warrant Liability
Warrant Liability	Note 7—Warrant Liability Public Warrants may only be exercised for a whole number of shares. No fractional Public Warrants will be issued upon separation of the Units and only whole Public Warrants will trade. The Public Warrants will become exercisable on the later of (a) 30 days after the completion of a Business Combination and (b) 12 months from the closing of the Proposed Public Offering; provided in each case that the Company has an effective registration statement under the Securities Act covering the issuance of the Class A ordinary shares issuable upon exercise of the Public Warrants and a current prospectus relating to them is available and such shares are registered, qualified or exempt from registration under the securities, or blue sky, laws of the state of residence of the holder (or the Company permits holders to exercise their Public Warrants on a cashless basis under the circumstances specified in the warrant agreement). The Company has agreed that as soon as practicable, but in no event later than 20 business days after the closing of the initial Business Combination, the Company will use its commercially reasonable efforts to file, and within 60 business days following the initial Business Combination to have declared effective, a registration statement covering the issuance of Class A ordinary shares issuable upon exercise of the warrants and to maintain a current prospectus relating to those Class A ordinary shares until the warrants expire or are redeemed; provided, that if the Class A ordinary shares are at the time of any exercise of a warrant not listed on a national securities exchange such that it satisfies the definition of a “covered security” under Section 18(b)(1) of the Securities Act, the Company may, at its option, require holders of Public Warrants who exercise their warrants to do so on a “cashless basis” in accordance with Section 3(a)(9) of the Securities Act and, in the event the Company so elects, it will not be required to file or maintain in effect a registration statement, but it will be required to use its best efforts to register or qualify the shares under applicable blue sky laws to the extent an exemption is not available. The Public Warrants will expire five years after the completion of a Business Combination or earlier upon redemption or liquidation. The warrants will have an exercise price of $11.50 per share. If (x) the Company issues additional shares or equity-linked securities for capital raising purposes in connection with the closing of the initial Business Combination at an issue price or effective issue price of less than $9.20 per share (as adjusted for stock splits, stock dividends, rights issuances, subdivisions, reorganizations, recapitalizations and the like) (with such issue price or effective issue price The Private Placement Warrants will be identical to the Public Warrants, except that (1) the Private Placement Warrants and the Class A ordinary shares issuable upon exercise of the Private Placement Warrants will not be transferable, assignable or salable until 30 days after the completion of a Business Combination, subject to certain limited exceptions, (2) the Private Placement Warrants will be non-redeemable (except as described below) so long as they are held by the Sponsor or its permitted transferees, (3) the Private Placement Warrants may be exercised by the holders on a cashless basis and (4) the holders of the Private Placement Warrants (including with respect to the ordinary shares issuable upon exercise of the Private Placement Warrants) are entitled to registration rights. If the Private Placement Warrants are held by someone other than the Sponsor or its permitted transferees, the Private Placement Warrants will be redeemable by the Company in all redemption scenarios and exercisable by such holders on the same basis as the Public Warrants. The Company may call the Public Warrants for redemption: • in whole and not in part; • at a price of $0.01 per warrant; • upon a minimum of 30 days’ prior written notice of redemption; and • if, and only if, the last reported sale price of the Class A ordinary shares equals or exceeds $18.00 per share (as adjusted for split-up of ordinary shares, share dividends, reorganizations, recapitalizations and the like) for any 20 trading days within the 30-trading day period ending on the third business day prior to the date on which the Company sends the notice of redemption to the warrant holders. If the Company calls the Public Warrants for redemption, management will have the option to require all holders that wish to exercise the Public Warrants to do so on a “cashless basis,” as described in the warrant agreement. In no event will the Company be required to net cash settle any warrant. If the Company is unable to complete a Business Combination within the Combination Period and the Company liquidates the funds held in the Trust Account, The Company accounts for the 18,845,000 warrants issued in connection with the Initial Public Offering (including 11,500,000 Public Warrants and 7,345,000 Private Placement Warrants) in accordance with the guidance contained in ASC 815-40. Such guidance provides that because the warrants do not meet the criteria for equity treatment thereunder, each warrant must be recorded as a liability. The accounting treatment of derivative financial instruments requires that the Company record the warrants as derivative liabilities at fair value upon the closing of the Initial Public Offering. The Public Warrants have been allocated a portion of the proceeds from the issuance of the Units equal to its fair value. These warrant liabilities are subject to re-measurement at each balance sheet date. With each such re-measurement, the warrant liability will be adjusted to its current fair value, with the change in fair value recognized in the Company’s statement of operations. The Company will reassess the classification at each balance sheet date. If the classification changes as a result of events during the period, the warrants will be reclassified as of the date of the event that causes the reclassification.

Shareholders Deficit

Shareholders Deficit	6 Months Ended
	Jun. 30, 2023
Shareholders Deficit
Shareholders' Deficit	Note 8—Shareholders’ Deficit Class A Ordinary Shares Class B Ordinary Shares Shareholders of record are entitled to one vote for each share held on all matters to be voted on by shareholders; provided that, prior to the completion of the initial Business Combination, holders of the Class B ordinary shares will have the right to elect all of the Company’s directors and remove members of the Board for any reason. Holders of the Public Shares will not be entitled to vote on the Company’s election of directors during such time. In addition, prior to the completion of the initial Business Combination, holders of a majority of the outstanding Class B ordinary shares may remove a member of the Board for any reason. These provisions of the Amended and Restated Memorandum and Articles of Association governing the appointment or removal of directors prior to the initial Business Combination may only be amended by a special resolution passed by no less than two-thirds of the Company’s ordinary shares who attend and vote at the Company’s general meeting which shall include the affirmative vote of a simple majority of the Company’s Class B ordinary shares. With respect to any other matter submitted to a vote of the Company’s shareholders, including any vote in connection with the initial Business Combination, holders of the Class A ordinary shares and holders of the Class B ordinary shares will vote together as a single class on all matters submitted to a vote of the Company’s shareholders, except as required by law. The Class B ordinary shares will automatically convert into Class A ordinary shares at the time of the initial Business Combination, or earlier at the option of the holders, on a one-for-one basis. In the case that additional Class A ordinary shares, or equity-linked securities, are issued or deemed issued in excess of the amounts issued in the Initial Public Offering and related to the closing of the initial Business Combination, including pursuant to a specified future issuance, the ratio at which Class B ordinary shares shall convert into Class A ordinary shares will be adjusted (unless the holders of a majority of the then-outstanding Class B ordinary shares agree to waive such adjustment with respect to any such issuance or deemed issuance, including a specified future issuance) so that the number of Class A ordinary shares issuable upon conversion of all Class B ordinary shares will equal, in the aggregate, on an as-converted basis, 20% of the sum of the total number of all ordinary shares outstanding upon the completion of the Proposed Public Offering plus all Class A ordinary shares and equity-linked securities issued or deemed issued in connection with the initial Business Combination (excluding any shares or equity-linked securities issued or issuable to any seller in the initial Business Combination). Preferred Shares Dividends The Company has not paid any cash dividends on the ordinary shares to date and does not intend to pay cash dividends prior to the completion of the initial Business Combination.

Fair Value Measurements

Fair Value Measurements	6 Months Ended
	Jun. 30, 2023
Fair Value Measurements
Fair Value Measurements	Note 9—Fair Value Measurements The following table presents information about the Company’s financial assets that are measured at fair value on a recurring basis as of June 30, 2023 and December 31, 2022, and indicates the fair value hierarchy of the valuation inputs the Company utilized to determine such fair value: As of June 30, 2023 Level 1 Level 2 Level 3 Total Assets: Investments held in Trust Account $ 241,463,580 $ — $ — $ 241,463,580 Total $ 241,463,580 $ — $ — $ 241,463,580 As of December 31, 2022 Level 1 Level 2 Level 3 Total Assets: Investments held in Trust Account $ 235,933,496 $ — $ — $ 235,933,496 Total $ 235,933,496 $ — $ — $ 235,933,496 As of June 30, 2023 Level 1 Level 2 Level 3 Total Liabilities: Warrant liability – Public Warrants $ 345,000 $ — $ — $ 345,000 Warrant liability - Private Placement Warrants — — 220,350 220,350 Total $ 345,000 $ — $ 220,350 $ 565,350 As of December 31, 2022 Level 1 Level 2 Level 3 Total Liabilities: Warrant liability – Public Warrants $ 345,000 $ — $ — $ 345,000 Warrant liability - Private Placement Warrants — — 220,350 220,350 Total $ 345,000 $ — $ 220,350 $ 565,350 As of June 30, 2023 and December 31, 2022, the estimated fair value of the Public Warrants was determined by their public trading price and the estimated fair value of the Private Placement Warrants was determined using a probability-adjusted Black-Scholes method to value the Private Placement Warrants at each reporting period, with changes in fair value recognized in the statement of operations. The estimated fair value of the Private Placement Warrants are determined using Level 3 inputs. Inherent in pricing models are assumptions related to expected share-price volatility, expected life, risk-free interest rate and dividend yield. The Company estimates the volatility of its ordinary shares based on historical volatility that matches the expected remaining life of the warrants. The risk-free interest rate is based on the U.S. Treasury zero-coupon yield curve on the grant date for a maturity similar to the expected remaining life of the warrants. The expected life of the warrants is assumed to be equivalent to their remaining contractual term. The dividend rate is based on the historical rate, which the Company anticipates to remain at zero. The following table provides the significant inputs to the probability-adjusted Black-Scholes method for the fair value of the Private Warrants: June 30, 2023 December 31, 2022 Stock price $ 10.47 $ 10.11 Exercise price $ 11.50 $ 11.50 Dividend yield - % - % Expected term (in years) 5 5 Volatility 3.2 % 2.3 % Risk-free rate 4.13 % 3.99 % Fair value $ 0.03 $ 0.03 The following tables provides a summary of the changes in the fair value of the Company’s Level 3 financial instruments that are measured at fair value on a recurring basis: Private Placement Warrants for the six months ended June 30, 2023 Fair value at January 1, 2023 $ 220,350 Change in fair value of Private Warrants - Fair value at June 30, 2023 $ 220,350 Private Placement Warrants for the six months ended June 30, 2022 Fair value at January 1, 2022 $ 3,819,400 Change in fair value of Private Warrants (2,938,000 ) Fair value at June 30, 2022 $ 881,400 Transfers to/from Levels 1, 2 and 3 are recognized at the end of the reporting period in which a change in valuation technique or methodology occurs.

Subsequent Events

Subsequent Events	6 Months Ended
	Jun. 30, 2023
Subsequent Events
Subsequent Events	Note 10—Subsequent Events The Company evaluated subsequent events and transactions that occurred after the balance sheet date up to the date that the financial statements were issued. Based upon this review, the Company did not identify any subsequent events that would have required adjustment or disclosure in the financial statements except as noted below. EGM and Extension On July 18, 2023, the Company held an EGM, at which the Company’s shareholders approved, among other things, an amendment to the Amended and Restated Memorandum and Articles of Association to (i) extend the date by which it has to complete a Business Combination from July 18, 2023 to October 18, 2023, and without another shareholder vote, to further extend the Termination Date for an additional one (1) month as needed, on a month-to-month basis, up to twelve (12) times, until October 18, 2024, and (ii) remove the limitation that the Company may not redeem Public Shares to the extent that such redemption would result in the Company having net tangible assets (as determined in accordance with Rule 3a51-1(g)(1) of the Exchange Act), of less than $5,000,001 in order to allow the Company to redeem Public Shares irrespective of whether such redemption would exceed the Redemption Limitation. In connection with the Charter Amendment, shareholders holding 12,391,198 Public Shares exercised their right to redeem such shares for a pro rata portion of the funds in the Trust Account. As a result, $130,320,650 (approximately $10.52 per share) was removed from the Trust Account to pay such holders. Following redemptions, the Company had 10,608,802 Public Shares outstanding and approximately $111,574,843 remaining in the Trust Account. On July 18, 2023, the Company and its trustee, Continental Stock Transfer & Trust Company (the “Trustee”), signed an amendment to the investment management trust agreement dated as of October 13, 2021 (the “Trust Agreement”), to reflect the terms of the Extension. Sponsor Handover On July 18, 2023, the Company entered into the Securities Purchase Agreement with the Company’s Prior Sponsor and the Purchaser, whereby the Prior Sponsor agreed to transfer to the Purchaser 3,046,634 of the Company’s Class B ordinary shares and 4,957,875 Private Placement Warrants purchased at the time of the Company’s IPO. In addition, all other holders of Class B ordinary shares transferred an aggregate of 1,380,866 of their Class B ordinary shares to Chunyi (Charlie) Hao pursuant to the Share Transfer Agreements executed by each respective holder on July 18, 2023. In connection with the Sponsor Handover, the Company, its officers and directors, the Sponsor and the Purchaser entered into additional agreements whereby: (a) the Purchaser and its designees signed the Joinder agreement to become a party to the Letter Agreement and the Registration Rights Agreement; and (b) the Letter Agreement was amended by the parties thereto to allow for the Transfer. In addition, at the Closing, the Company’s IPO underwriters waived their respective entitlement to the payment of any deferred underwriting fees to be paid under the terms of Section 2(c) and Section 5(bb) of the Underwriting Agreement. As part of the Sponsor Handover, the Company introduced a change in management and the Board as follows: (i) effective as of July 18, 2023, Chunyi (Charlie) Hao replaced William M. Mounger as Chief Executive Officer and director, and Michael H. Liu replaced Timothy Allen Dawson as Chief Financial Officer, and Mr. Liu was also appointed as a director of the Board; (ii) effective as of July 18, 2023, Cathy Martine-Dolecki tendered her resignation as Chief Operating Officer and director and Robert Willis tendered his resignation as director; and (iii) Greg Boyd, David Jones, David Barksdale, Alex Parker and Steven Rogers tendered their resignations as directors, to be effective upon the later of (x) the expiration of all applicable waiting periods under Section 14(f) of the Exchange Act and Rule 14f-1 thereunder, (y) the Company’s filing of this quarterly report on Form 10-Q for the period ended June 30, 2023, and (z) the appointment of their successors to be designated by the Sponsor. The Company has designated each of Xinyue (Jasmine) Geffner, Stephen Markscheid and Wang Chiu (Tommy) Wong to fill the vacancies left by departing Messrs. Boyd, Jones, Barksdale, Parker and Rogers, and effective upon expiration of the Waiting Period. In connection with the Closing, on July 18, 2023, the Purchaser caused $375,000 to be deposited into the Trust Account to support the first three months of the Extension from July 18, 2023 to October 18, 2023. The Purchaser has agreed to deposit into the Trust Account an additional $125,000 for each successive month, or portion thereof, that is needed by the Company to complete an initial Business Combination until October 18, 2024. On July 18, 2023, the Company issued an unsecured promissory note in an amount of $375,000, to Chunyi (Charlie) Hao, for having depositing into the Trust Account $375,000 in order to support the first three months of the Extension from July 18, 2023 to October 18, 2023. The July 2023 Extension Note does not bear interest and will be due and payable by the Maker on the earlier (a) the date that the Company consummates an initial Business Combination and (b) the date of the liquidation of the Company.

Significant Accounting Polici_2

Significant Accounting Policies (Policies)	6 Months Ended
	Jun. 30, 2023
Significant Accounting Policies
Basis of presentation	The accompanying financial statement is presented in conformity with accounting principles generally accepted in the United States of America (“GAAP”) and pursuant to the rules and regulations of the SEC, and reflect all adjustments, consisting only of normal recurring adjustments, which are, in the opinion of management, necessary for the fair presentation of the financial position as of June 30, 2023 and the results of operations and cash flows for the period presented and should be read in conjunction with the Company’s Annual Report on Form 10-K for the year ended December 31, 2022. The financial information as of December 31, 2022 is derived from the audited financial statements presented in the Company’s Annual Report on Form 10-K for the year ended December 31, 2022. The interim results for the three and six months ended June 30, 2023 are not necessarily indicative of the results to be expected for the year ending December 31, 2023 or for any future periods.
Emerging Growth Company	The Company is an “emerging growth company,” as defined in Section 2(a) of the Securities Act, as modified by the Jumpstart our Business Startups Act of 2012 (the “JOBS Act”), and it may take advantage of certain exemptions from various reporting requirements that are applicable to other public companies that are not emerging growth companies including, but not limited to, not being required to comply with the auditor attestation requirements of Section 404 of the Sarbanes-Oxley Act, reduced disclosure obligations regarding executive compensation in its periodic reports and proxy statements, and exemptions from the requirements of holding a nonbinding advisory vote on executive compensation and shareholder approval of any golden parachute payments not previously approved. Further, section 102(b)(1) of the JOBS Act exempts emerging growth companies from being required to comply with new or revised financial accounting standards until private companies (that is, those that have not had a Securities Act registration statement declared effective or do not have a class of securities registered under the Exchange Act) are required to comply with the new or revised financial accounting standards. The JOBS Act provides that an emerging growth company can elect to opt out of the extended transition period and comply with the requirements that apply to non-emerging growth companies but any such election to opt out is irrevocable. The Company has elected not to opt out of such extended transition period which means that when a standard is issued or revised and it has different application dates for public or private companies, the Company, as an emerging growth company, can adopt the new or revised standard at the time private companies adopt the new or revised standard. This may make comparison of the Company’s financial statements with another public company which is neither an emerging growth company nor an emerging growth company which has opted out of using the extended transition period difficult or impossible because of the potential differences in accounting standards used.
Use of Estimates	The preparation of the financial statements in conformity with U.S. GAAP requires the Company’s management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of expenses during the reporting period. Making estimates requires management to exercise significant judgment. It is at least reasonably possible that the estimate of the effect of a condition, situation or set of circumstances that existed at the date of the financial statements, which management considered in formulating its estimate, could change in the near term due to one or more future confirming events. Accordingly, the actual results could differ from those estimates.
Cash and Cash Equivalents	The Company considers all short-term investments with an original maturity of three months or less when purchased to be cash equivalents. The Company did not have any cash equivalents as of June 30, 2023 and December 31, 2022.
Investments Held in Trust Account	As of June 30, 2023 and December 31, 2022, the assets held in Trust Account were held in money market funds, which invest in U.S. Treasury securities. The Company’s portfolio of investments held in the Trust Account is comprised of U.S. government securities, within the meaning set forth in Section 2(a)(16) of the Investment Company Act, with a maturity of 185 days or less, or investments in money market funds that invest in U.S. government securities, or a combination thereof. The Company classifies its U.S. Treasury securities as trading securities in accordance with FASB ASC 320 “Investments—Debt and Equity Securities.”
Class A Ordinary Shares Subject to Possible Redemption	The Company accounts for its ordinary shares subject to possible redemption in accordance with the guidance in ASC 480. Ordinary shares subject to mandatory redemption are classified as a liability instrument and are measured at fair value. Conditionally redeemable ordinary shares (including ordinary shares that feature redemption rights that are either within the control of the holder or subject to redemption upon the occurrence of uncertain events not solely within the Company’s control) are classified as temporary equity. At all other times, ordinary shares are classified as shareholders’ equity. The Company’s ordinary shares feature certain redemption rights that are considered to be outside of the Company’s control and subject to the occurrence of uncertain future events. The Company recognizes changes in redemption value immediately as they occur and adjusts the carrying value of redeemable Class A ordinary shares to equal the redemption value at the end of each reporting period. Increases or decreases in the carrying amount of redeemable Class A ordinary shares are affected by charges against additional paid-in capital and accumulated deficit. As of June 30, 2023 and December 31, 2022, 23,000,000 Class A ordinary shares subject to possible redemption are presented at redemption value as temporary equity, outside of the shareholders’ deficit section of the Company’s balance sheet.
Offering Costs associated with the Initial Public Offering	The Company complies with the requirements of ASC 340-10-S99-1 and SEC Staff Accounting Bulletin Topic 5A - Expenses of Offering
Income Taxes	The Company accounts for income taxes under ASC 740, Income Taxes ASC 740 also clarifies the accounting for uncertainty in income taxes recognized in an enterprise’s financial statements and prescribes a recognition threshold and measurement process for financial statement recognition and measurement of a tax position taken or expected to be taken in a tax return. For those benefits to be recognized, a tax position must be more-likely-than-not to be sustained upon examination by taxing authorities. ASC 740 also provides guidance on derecognition, classification, interest and penalties, accounting in interim period, disclosure and transition. Based on the Company’s evaluation, it has been concluded that there are no significant uncertain tax positions requiring recognition in the Company’s financial statements. Since the Company was incorporated on March 5, 2021, the evaluation was performed for the 2022 and 2021 tax years which will be the only periods subject to examination. The Company recognizes accrued interest and penalties related to unrecognized tax benefits as income tax expense. There were no unrecognized tax benefits and no amounts accrued for interest and penalties as of June 30, 2023 and December 31, 2022. The Company is currently not aware of any issues under review that could result in significant payments, accruals or material deviation from its position. There are no taxes in the Cayman Islands and accordingly income taxes are not levied on the Company. Consequently, income taxes are not reflected in the Company’s financial statements.
Share-based Compensation	The Company adopted ASC Topic 718, Compensation—Stock Compensation, guidance to account for its share-based compensation. It defines a fair value-based method of accounting for an employee share option or similar equity instrument. The Company recognizes all forms of share-based payments, including share option grants, warrants and restricted share grants, at their fair value on the grant date, which are based on the estimated number of awards that are ultimately expected to vest. Share-based payments, excluding restricted shares, are valued using a Black-Scholes option pricing model. Grants of share-based payment awards issued to nonemployees for services rendered have been recorded at the fair value of the share based payment, which is the more readily determinable value. The grants are amortized on a straight-line basis over the requisite service periods, which is generally the vesting period. If an award is granted, but vesting does not occur, any previously recognized compensation cost is reversed in the period related to the termination of service. Share-based compensation expenses are included in costs and operating expenses depending on the nature of the services provided in the statements of operations.
Concentration of Credit Risk	Financial instruments that potentially subject the Company to concentrations of credit risk consist of a cash account in a financial institution, which, at times, may exceed the Federal Depository Insurance Coverage of $250,000. The Company has not experienced losses on this account and management believes the Company is not exposed to significant risks on such account.
Derivative Financial Instruments	The Company evaluates its financial instruments to determine if such instruments are derivatives or contain features that qualify as embedded derivatives in accordance with ASC Topic 815, “Derivatives and Hedging.” Derivative instruments are initially recorded at fair value on the grant date and re-valued at each reporting date, with changes in the fair value reported in the statements of operations. Derivative assets and liabilities are classified in the balance sheet as current or non-current based on whether or not net-cash settlement or conversion of the instrument could be required within 12 months of the balance sheet date.
Warrant Liabilities	The Company evaluated the Public Warrants and Private Placement Warrants (collectively, “Warrants”), in accordance with ASC 815-40, “Derivatives and Hedging -- Contracts in Entity’s Own Equity,” and concluded that a provision in the Warrant Agreement related to certain tender or exchange offers precludes the Warrants from being accounted for as components of equity. As the Warrants meet the definition of a derivative as contemplated in ASC 815, the Warrants are recorded as derivative liabilities on the balance sheet and measured at fair value at inception (on the date of the IPO) and at each reporting date in accordance with ASC 820, “Fair Value Measurement,” with changes in fair value recognized in the statement of operations in the period of change.
Fair Value of Financial Instruments	ASC 820 establishes a fair value hierarchy that prioritizes and ranks the level of observability of inputs used to measure investments at fair value. The observability of inputs is impacted by a number of factors, including the type of investment, characteristics specific to the investment, market conditions and other factors. The hierarchy gives the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (Level 1 measurements) and the lowest priority to unobservable inputs (Level 3 measurements). Investments with readily available quoted prices or for which fair value can be measured from quoted prices in active markets will typically have a higher degree of input observability and a lesser degree of judgment applied in determining fair value. The carrying amounts reflected in the balance sheet for cash, prepaid expenses, due from related party, investments held in Trust Account, accounts payable, and accrued offering costs and expenses approximate fair value due to their short-term nature. The three levels of the fair value hierarchy under ASC 820 are as follows: Level 1—Quoted prices (unadjusted) in active markets for identical investments at the measurement date are used. Level 2—Pricing inputs are other than quoted prices included within Level 1 that are observable for the investment, either directly or indirectly. Level 2 pricing inputs include quoted prices for similar investments in active markets, quoted prices for identical or similar investments in markets that are not active, inputs other than quoted prices that are observable for the investment, and inputs that are derived principally from or corroborated by observable market data by correlation or other means. Level 3—Pricing inputs are unobservable and include situations where there is little, if any, market activity for the investment. The inputs used in determination of fair value require significant judgment and estimation. In some cases, the inputs used to measure fair value might fall within different levels of the fair value hierarchy. In such cases, the level in the fair value hierarchy within which the investment is categorized in its entirety is determined based on the lowest level input that is significant to the investment. Assessing the significance of a particular input to the valuation of an investment in its entirety requires judgment and considers factors specific to the investment. The categorization of an investment within the hierarchy is based upon the pricing transparency of the investment and does not necessarily correspond to the perceived risk of that investment. See Note 9 for additional information on assets and liabilities measured at fair value.
Net Income Per Ordinary Share	The Company applies the two-class method in calculating net income per ordinary share. The contractual formula utilized to calculate the redemption amount approximates fair value. The Class feature to redeem at fair value means that there is effectively only one class of ordinary share. Changes in fair value are not considered a dividend of the purposes of the numerator in the earnings per share calculation. Net income per ordinary share is computed by dividing the pro rata net income between the Class A ordinary share and the Class B ordinary share by the weighted average number of ordinary shares outstanding. The calculation of diluted income per ordinary share does not consider the effect of the warrants and rights issued in connection with the Public Offering since the exercise of the warrants and rights are contingent upon the occurrence of future events and the inclusion of such warrants would be anti-dilutive. The warrants and rights are exercisable for 18,845,000 shares of Class A ordinary share in the aggregate. For the three months ended June 30, 2023 For the three months ended June 30, 2022 Ordinary shares subject to possible redemption Numerator: Earnings allocable to Redeemable Class A ordinary shares Net income allocable to Class A ordinary shares subject to possible redemption $ 3,692,422 $ 4,191,010 Denominator: Redeemable Class A ordinary shares, Basic and diluted weighted average shares outstanding 23,000,000 23,000,000 Basic and diluted net income per share, Redeemable Class A ordinary share $ 0.16 $ 0.18 Non-redeemable ordinary shares Numerator: Net income allocable to Class B ordinary shares not subject to redemption Net income allocable to Class B ordinary shares not subject to redemption $ 923,105 $ 1,047,752 Denominator: Weighted Average non-redeemable Class B ordinary shares Basic and diluted weighted average shares outstanding 5,750,000 5,750,000 Basic and diluted net income per share $ 0.16 $ 0.18 For the six months ended June 30, 2023 For the six months ended June 30, 2022 Ordinary shares subject to possible redemption Numerator: Earnings allocable to Redeemable Class A ordinary shares Net income allocable to Class A ordinary shares subject to possible redemption $ 4,320,518 $ 5,706,623 Denominator: Redeemable Class A ordinary shares, Basic and diluted weighted average shares outstanding 23,000,000 23,000,000 Basic and diluted net income per share, Redeemable Class A ordinary share $ 0.19 $ 0.25 Non-redeemable ordinary shares Numerator: Net income allocable to Class B ordinary shares not subject to redemption Net income allocable to Class B ordinary shares not subject to redemption $ 1,080,130 $ 1,426,656 Denominator: Weighted Average non-redeemable Class B ordinary shares Basic and diluted weighted average shares outstanding 5,750,000 5,750,000 Basic and diluted net income per share $ 0.19 $ 0.25

Significant Accounting Polici_3

Significant Accounting Policies (Tables)	6 Months Ended
	Jun. 30, 2023
Significant Accounting Policies
Schedule of Earnings Per Share, Basic and Diluted	For the three months ended June 30, 2023 For the three months ended June 30, 2022 Ordinary shares subject to possible redemption Numerator: Earnings allocable to Redeemable Class A ordinary shares Net income allocable to Class A ordinary shares subject to possible redemption $ 3,692,422 $ 4,191,010 Denominator: Redeemable Class A ordinary shares, Basic and diluted weighted average shares outstanding 23,000,000 23,000,000 Basic and diluted net income per share, Redeemable Class A ordinary share $ 0.16 $ 0.18 Non-redeemable ordinary shares Numerator: Net income allocable to Class B ordinary shares not subject to redemption Net income allocable to Class B ordinary shares not subject to redemption $ 923,105 $ 1,047,752 Denominator: Weighted Average non-redeemable Class B ordinary shares Basic and diluted weighted average shares outstanding 5,750,000 5,750,000 Basic and diluted net income per share $ 0.16 $ 0.18 For the six months ended June 30, 2023 For the six months ended June 30, 2022 Ordinary shares subject to possible redemption Numerator: Earnings allocable to Redeemable Class A ordinary shares Net income allocable to Class A ordinary shares subject to possible redemption $ 4,320,518 $ 5,706,623 Denominator: Redeemable Class A ordinary shares, Basic and diluted weighted average shares outstanding 23,000,000 23,000,000 Basic and diluted net income per share, Redeemable Class A ordinary share $ 0.19 $ 0.25 Non-redeemable ordinary shares Numerator: Net income allocable to Class B ordinary shares not subject to redemption Net income allocable to Class B ordinary shares not subject to redemption $ 1,080,130 $ 1,426,656 Denominator: Weighted Average non-redeemable Class B ordinary shares Basic and diluted weighted average shares outstanding 5,750,000 5,750,000 Basic and diluted net income per share $ 0.19 $ 0.25

Fair Value Measurements (Tables

Fair Value Measurements (Tables)	6 Months Ended
	Jun. 30, 2023
Fair Value Measurements
Fair Value, of Assets and Liabilities Measured on Recurring Basis	As of June 30, 2023 Level 1 Level 2 Level 3 Total Assets: Investments held in Trust Account $ 241,463,580 $ — $ — $ 241,463,580 Total $ 241,463,580 $ — $ — $ 241,463,580 As of December 31, 2022 Level 1 Level 2 Level 3 Total Assets: Investments held in Trust Account $ 235,933,496 $ — $ — $ 235,933,496 Total $ 235,933,496 $ — $ — $ 235,933,496 As of June 30, 2023 Level 1 Level 2 Level 3 Total Liabilities: Warrant liability – Public Warrants $ 345,000 $ — $ — $ 345,000 Warrant liability - Private Placement Warrants — — 220,350 220,350 Total $ 345,000 $ — $ 220,350 $ 565,350 As of December 31, 2022 Level 1 Level 2 Level 3 Total Liabilities: Warrant liability – Public Warrants $ 345,000 $ — $ — $ 345,000 Warrant liability - Private Placement Warrants — — 220,350 220,350 Total $ 345,000 $ — $ 220,350 $ 565,350
Disclosure Of Measurement Inputs For Fair Value Of Private Warrants	June 30, 2023 December 31, 2022 Stock price $ 10.47 $ 10.11 Exercise price $ 11.50 $ 11.50 Dividend yield - % - % Expected term (in years) 5 5 Volatility 3.2 % 2.3 % Risk-free rate 4.13 % 3.99 % Fair value $ 0.03 $ 0.03
Fair Value of financial instruments	Private Placement Warrants for the six months ended June 30, 2023 Fair value at January 1, 2023 $ 220,350 Change in fair value of Private Warrants - Fair value at June 30, 2023 $ 220,350 Private Placement Warrants for the six months ended June 30, 2022 Fair value at January 1, 2022 $ 3,819,400 Change in fair value of Private Warrants (2,938,000 ) Fair value at June 30, 2022 $ 881,400

Description of Organization a_2

Description of Organization and Business Operations and Liquidity (Detail Narrative) - USD ($)		1 Months Ended	6 Months Ended
	Nov. 03, 2021	Oct. 18, 2021	Jun. 30, 2023	Dec. 31, 2022
Entity Incorporation Date Of Incorporation			Mar. 05, 2021
Term of restricted investments			185 days
Temporary equity, redemption price per share			$ 10.50
Percentage of public shares subject to restriction			15%
Percentage of public shares to be redeemed in case initial business combination is not completed			100%
Interest to pay dissolution expenses			$ 100,000
Liquidation basis of accounting, accrued costs to dispose of assets and liabilities			$ 100,000
Per share value of the residual assets remaining available for distribution including Trust Account assets			$ 10.10
Temporary equity, liquidation preference per share			$ 10.10
Redemption of shares limited amount			$ 5,000,001
Cash			13,751	$ 587,546
Proceeds from issuance of warrants	$ 7,345,000
Gross proceeds from initial public offer		$ 200,000,000
Deferred underwriting fee payable non current			0	$ 10,350,000
Offering costs			$ 25,995,754
Common Class A [Member]
Temporary equity, redemption price per share			$ 10.50	$ 10.26
Charter Amendment [Member]
Temporary equity, redemption price per share			$ 10.52
Public shares outstanding			10,608,802
Shares authorized by shareholders			12,391,198
Payment to shareholders			$ 130,320,650
Securities Purchase Agreement [Member]
Warrants to purchased			4,957,875
Number of ordinary shares transferred			1,380,866
Purchaser of shares			3,046,634
Deposited into the Trust Account			$ 375,000
Trust Account an additional amount			125,000
Unsecured promissory note			375,000
Deposit into Trust Account			$ 375,000
Minimum [Member]
Prospective assets of acquire as a percentage of fair value of assets in the trust account			100%
Private Placement Warrant [Member]
Stock issued during period, Shares	3,000,000
Class of warrants or rights issued during period, warrants			6,775,000
Class of warrants or rights issued during period, price per warrant			$ 1
Over-Allotment Option [Member]
Shares issued, price per share		$ 10
Gross proceeds from common stock issuance	$ 30,000,000
Over-Allotment Option [Member] | Private Placement Warrant [Member]
Stock issued during period, Shares			570,000
Class of warrants or rights issued during period, price per warrant			$ 1
Private Placement And Over Allotment Option [Member] | Private Placement Warrant [Member] | Sponsor [Member]
Class of warrants or rights issued during period, warrants	7,345,000
Private Placement [Member] | Private Placement Warrant [Member] | Sponsor [Member]
Class of warrants or rights issued during period, price per warrant		$ 1
IPO [Member]
Payment to acquire restricted investments			$ 232,300,000
Transaction costs			25,995,754
Underwriting fees			4,600,000
Deferred underwriting fee payable non current			10,350,000
Transaction costs anchor investors			12,546,764
Offering costs			1,003,989
Reimbursement of offering costs from underwriters			$ 2,505,000
Proposed Public Offering [Member] | Common Class A [Member]
Stock issued during period, Shares		20,000,000
Shares issued, price per share		$ 10
Proposed Public Offering [Member] | Underwriters [Member]
Stock issued during period, Shares		20,000,000

Significant Accounting Polici_4

Significant Accounting Policies (Details) - USD ($)	3 Months Ended				6 Months Ended
	Jun. 30, 2023	Mar. 31, 2023	Jun. 30, 2022	Mar. 31, 2022	Jun. 30, 2023	Jun. 30, 2022
Net income allocable to Class A ordinary shares subject to possible redemption	$ 4,615,527	$ 785,121	$ 5,238,762	$ 1,894,517	$ 5,400,648	$ 7,133,279
Common Class B [Member] | Non Redeemable Common Stock [Member]
Net income allocable to Class A ordinary shares subject to possible redemption	$ 923,105		$ 1,047,752		$ 1,080,130	$ 1,426,656
Basic and diluted weighted average shares outstanding	5,750,000		5,750,000		5,750,000	5,750,000
Basic and diluted net income per share	$ 0.16		$ 0.18		$ 0.19	$ 0.25
Common Class A [Member] | Non Redeemable Common Stock [Member]
Net income allocable to Class A ordinary shares subject to possible redemption	$ 3,692,422		$ 4,191,010		$ 4,320,518	$ 5,706,623
Basic and diluted weighted average shares outstanding	23,000,000		23,000,000		23,000,000	23,000,000
Basic and diluted net income per share, Redeemable Class A ordinary share	$ 0.16		$ 0.18		$ 0.19	$ 0.25

Significant Accounting Polici_5

Significant Accounting Policies (Detail Narrative) - USD ($)	6 Months Ended
	Jun. 30, 2023	Dec. 31, 2022
Deferred underwriting fee payable	$ 0	$ 10,350,000
FDIC Limit	250,000
Offering costs	$ 25,995,754
Warrants To Subscribe For Class A Common Stock [Member]
Class of warrants or rights number of securities covered by the warrants or rights	18,845,000
IPO [Member]
Transaction costs	$ 25,995,754
Underwriting fees	4,600,000
Deferred underwriting fee payable	10,350,000
Transaction costs anchor investors	12,546,764
Offering costs	1,003,989
Reimbursement of offering costs from underwriters	2,505,000
Offering costs charged to stockholders deficit	24,414,399
Offering costs expensed	$ 1,581,355

Initial Public Offering (Detail

Initial Public Offering (Detail Narrative) - $ / shares	1 Months Ended
	Oct. 18, 2021	Jun. 30, 2023	Nov. 03, 2021	Oct. 13, 2021
Common Class A [Member] | Share Price Equals Or Exceeds Twelve USD [Member]
Share Price		$ 11.50
Over-Allotment Option [Member]
Shares issued, price per share	$ 10
Over-Allotment Option [Member] | Underwriters [Member]
Common Stock, Shares Subscribed but Unissued			3,000,000	3,000,000
Proposed Public Offering [Member] | Underwriters [Member]
Stock issued during period, Shares	20,000,000
Proposed Public Offering [Member] | Common Class A [Member]
Stock issued during period, Shares	20,000,000
Shares issued, price per share	$ 10
Common Stock, Conversion Basis	Each Unit consists of one Class A ordinary share and one-half of one redeemable warrant (“Public Warrant”).
Proposed Public Offering [Member] | Common Class A [Member] | Public Warrant [Member]
Class of Warrant or Right, Exercise Price of Warrants or Rights	$ 11.50

Private Placement (Detail Narra

Private Placement (Detail Narrative) - Private Placement Warrant [Member] - $ / shares		6 Months Ended
	Nov. 03, 2021	Jun. 30, 2023
Class of warrants or rights issued during period, warrants		6,775,000
Class of warrants or rights issued during period, price per warrant		$ 1
Stock issued during period, Shares	3,000,000
Class of warrants or rights exercise price per unit		$ 11.50
Private placement warrants		4,957,875
Over-Allotment Option [Member]
Class of warrants or rights issued during period, price per warrant		$ 1
Stock issued during period, Shares		570,000

Related Party Transactions (Det

Related Party Transactions (Detail Narrative) - USD ($)		1 Months Ended		6 Months Ended
	Jun. 12, 2023	Oct. 18, 2021	Aug. 31, 2021	Jun. 30, 2023	Dec. 31, 2022	Nov. 03, 2021	Mar. 15, 2021
Net drawdown from sponsor				$ 158,968
Proceeds from Loan from sponsor	$ 250,000
Estimated fair value of founder shares at the closing of public offering				$ 13,562,614
Estimated fair value of founder shares at the closing of public offering per share				$ 7.07
Offering Costs For Shares Issued To The Founder				$ 1,015,850
Founder Share [Member]
Sale of stock issue price per share				$ 7.44
Stock issued during period, value, issued for services				$ 1,116,000
Working Capital Loan [Member]
Debt instrument, convertible, carrying amount of equity component				1,500,000
Sponsor [Member] | Founder Share [Member] | One Of The Anchor Investors [Member]
Sale of stock, number of shares issued in transaction		333,333
Sale of stock, price per share		$ 3
Sponsor [Member] | Founder Share [Member] | Other Anchor Investors [Member]
Sale of stock, number of shares issued in transaction		1,585,000
Sale of stock, price per share		$ 0.01
Sponsor [Member] | Service And Administrative Fees [Member]
Related party transaction, amounts of transaction				10,000
Sponsor [Member] | Service And Administrative Fees [Member] | Accrued Liabilities [Member]
Accounts payable due to related party current				$ 204,516	$ 144,516
Common Class A [Member]
Common stock par or stated value per share				$ 0.0001	$ 0.0001
Common stock shares outstanding				0	0
Number of trading days for determining the share price				20 days
Number of consecutive trading days for determining the share price				30 days
Threshold number of days determining share price				150 days
Common Class A [Member] | Share Price Equals Or Exceeds Twelve USD [Member]
Share Price				$ 11.50
Common Class A [Member] | Proposed Public Offering [Member]
Sale of stock issue price per share		$ 10
Common Class A [Member] | Related Party Transaction [Member] | Share Price Equals Or Exceeds Twelve USD [Member]
Share Price				12
Common Class A [Member] | Anchor Investors [Member] | Proposed Public Offering [Member]
Share Price						$ 10
Common Class B [Member]
Common stock par or stated value per share				$ 0.0001	$ 0.0001
Common stock shares outstanding				5,750,000	5,750,000
Common Class B [Member] | Sponsor [Member]
Common stock, shares subscribed but unissued							7,187,500
Stock forfeited during period, Shares			1,437,500
Common stock shares outstanding				5,750,000
Common Class B [Member] | Sponsor [Member] | Before Forfeiture [Member]
Common stock shares outstanding			7,187,500

Commitments and Contingencies (

Commitments and Contingencies (Detail Narrative) - USD ($)	1 Months Ended		3 Months Ended	6 Months Ended
	Jun. 23, 2023	Feb. 28, 2023	Jun. 30, 2023	Jun. 30, 2023	Nov. 03, 2021
Underwriting discount payable per unit			$ 0.20	$ 0.20
Forgiveness of deferred underwriting fee			$ 9,868,725
Business Acquisition, Transaction Costs			525,000	$ 525,000
Accrued unbilled reimbursable costs			$ 98,089	$ 98,089
Percentage of cash and fair market value of other property			3.50%	3.50%
Success fee from investment banking		$ 10,000,000
Underwriting Agreement [Member]
Waived off deferred underwriting commission	$ 10,350,000
Derecognized deferred underwriting fee payable	10,350,000
Forgiveness of deferred underwriting fee	9,868,725
Gain from extinguishment of liability	$ 481,275
Deferred compensation liability classified noncurrent per unit			$ 0.45	$ 0.45
Over-Allotment Option [Member] | Underwriting Agreement [Member]
Underwriting discount payable			$ 10,350,000	$ 10,350,000
Anchor Investors [Member] | Common Class A [Member] | Proposed Public Offering [Member]
Share price					$ 10
Forward Purchase Agreements [Member] | Common Class A [Member] | Private Placement [Member]
Common stock, shares subscribed but unissued			4,500,000	4,500,000
Forward Purchase Agreements [Member] | Investor [Member]
Debt instrument committed to be purchased by investors				$ 25,000,000

Warrant Liability (Detail Narra

Warrant Liability (Detail Narrative)	6 Months Ended
	Jun. 30, 2023 $ / shares shares
Class of warrant or right, outstanding | shares	18,845,000
Public Warrants [Member]
Class of warrant or right, outstanding | shares	11,500,000
Number of days after which the warrants are exercisable from the consummation of initial business combination	30 days
Number of days after which the warrants are exercisable from the closing of initial public offering	12 months
Number of days within which the securities shall be registered with the securities exchange commission from the consummation of initial business combination	20 days
Number of days within which the securities registration shall be made effective from the consummation of business combination	60 days
Sale of stock issue price per share	$ 11.50
Class of warrants or rights redemption price per warrant	$ 0.01
Minimum notice period to be given to the holders of warrant prior to redemption	30 days
Public Warrants [Member] | Prospective Warrant Redemption [Member]
Number of trading days for determining the share price	20 days
Number of consecutive trading days for determining the share price	30 days
Share price	$ 18
Public Warrants [Member] | Event Triggering Adjustment To Exercise Price Of Warrants [Member]
Number of consecutive trading days for determining the share price	20 days
Share price	$ 18
Sale of stock issue price per share	$ 9.20
Proceeds to be used for effectuating business combination as a percentage of the total proceeds	60%
Volume weighted average price per share	$ 9.20
Adjusted exercise price of warrants percentage	115%
Adjusted share price percentage	180%
Private Placement Warrants [Member]
Class of warrant or right, outstanding | shares	7,345,000
Lock in period of warrants	30 days

Shareholders Deficit (Detail Na

Shareholders Deficit (Detail Narrative) - $ / shares	Jun. 30, 2023	Dec. 31, 2022
Preferred stock shares authorized	1,000,000	1,000,000
Preferred stock par value	$ 0.0001	$ 0.0001
Preferred stock shares issued	0	0
Preferred stock shares outstanding	0	0
Common Class A [Member]
Common stock shares authorized	90,000,000	90,000,000
Common stock par or stated value per share	$ 0.0001	$ 0.0001
Common stock shares issued	0	0
Common stock shares outstanding	0	0
Temporary Equity, Shares Outstanding	23,000,000	23,000,000
Common Class B [Member]
Common stock shares authorized	10,000,000	10,000,000
Common stock par or stated value per share	$ 0.0001	$ 0.0001
Common stock shares issued	5,750,000	5,750,000
Common stock shares outstanding	5,750,000	5,750,000
Prospective Conversion From Class B To Class A Common Stock [Member]
Common stock shares outstanding on conversion from one class to another	20%
Preferred Share [Member]
Preferred stock shares authorized	1,000,000	1,000,000
Preferred stock par value	$ 0.0001	$ 0.0001

Fair Value Measurements (Detail

Fair Value Measurements (Details) - USD ($)	Jun. 30, 2023	Dec. 31, 2022
Investments held in Trust Account	$ 241,463,580	$ 235,933,496
Warrant liability	565,350	565,350
Total	241,463,580	235,933,496
Fair Value, Inputs, Level 1 [Member]
Investments held in Trust Account	241,463,580	235,933,496
Warrant liability	345,000	345,000
Total	241,463,580	235,933,496
Fair Value, Inputs, Level 2 [Member]
Investments held in Trust Account	0	0
Warrant liability	0	0
Total	0	0
Fair Value, Inputs, Level 3 [Member]
Investments held in Trust Account	0	0
Warrant liability	220,350	220,350
Total	0	0
Private Placement Warrants [Member]
Warrant liability	220,350	220,350
Private Placement Warrants [Member] | Fair Value, Inputs, Level 1 [Member]
Warrant liability	0	0
Private Placement Warrants [Member] | Fair Value, Inputs, Level 2 [Member]
Warrant liability	0	0
Private Placement Warrants [Member] | Fair Value, Inputs, Level 3 [Member]
Warrant liability	220,350	220,350
Public Warrant [Member]
Warrant liability	345,000	345,000
Public Warrant [Member] | Fair Value, Inputs, Level 1 [Member]
Warrant liability	345,000	345,000
Public Warrant [Member] | Fair Value, Inputs, Level 2 [Member]
Warrant liability	0	0
Public Warrant [Member] | Fair Value, Inputs, Level 3 [Member]
Warrant liability	$ 0	$ 0

Fair Value Measurements (Deta_2

Fair Value Measurements (Detail 1)	Jun. 30, 2023	Dec. 31, 2022
Warrants and Rights Outstanding, Measurement Input	0.03	0.03
Measurement Input, Share Price [Member]
Warrants and Rights Outstanding, Measurement Input	10.47	10.11
Measurement Input, Exercise Price [Member]
Warrants and Rights Outstanding, Measurement Input	11.50	11.50
Measurement Input, Expected Dividend Rate [Member]
Warrants and Rights Outstanding, Measurement Input	0	0
Measurement Input, Expected Term [Member]
Warrants and Rights Outstanding, Measurement Input	5	5
Measurement Input, Price Volatility [Member]
Warrants and Rights Outstanding, Measurement Input	3.2	2.3
Measurement Input, Risk Free Interest Rate [Member]
Warrants and Rights Outstanding, Measurement Input	4.13	3.99

Fair Value Measurements (Deta_3

Fair Value Measurements (Details 2) - Private Placement Warrant [Member] - Warrants [Member] - USD ($)	6 Months Ended
	Jun. 30, 2023	Jun. 30, 2022
Beginning Balance, Fair value	$ 220,350	$ 3,819,400
Change in fair value of Private Warrants	0	(2,938,000)
Ending Balance, Fair value	$ 220,350	$ 881,400

Subsequent Events (Details Narr

Subsequent Events (Details Narrative) - USD ($)	1 Months Ended	3 Months Ended	6 Months Ended
	Jul. 18, 2023	Oct. 18, 2023	Jun. 30, 2023
Payment to shareholders, per share price			$ 10.50
Charter Amendment [Member]
Shares authorized by shareholders			12,391,198
Payment to shareholders, per share price			$ 10.52
Public shares outstanding			10,608,802
Payment to shareholders			$ 130,320,650
Subsequent Event [Member] | Sponsor Handover [Member]
Amount additional deposited for extension to support trust		$ 125,000
Amount deposited for extension to support trust		375,000
Subsequent Event [Member] | Sponsor Handover [Member] | Common Class B [Member]
Number of ordinary share transfer to purchaser	3,046,634
Private placement warrant purchase	4,957,875
Subsequent Event [Member] | Sponsor Handover [Member] | Common Class B [Member] | Chunyi (Charlie) Hao [Member]
Number of ordinary share transfer to purchaser	1,380,866
Subsequent Event [Member] | July 2023 Extension Note [Member] | Chunyi (Charlie) Hao [Member]
Amount deposited for extension to support trust		$ 375,000
Issued of unsecured promissory note	$ 375,000
Subsequent Event [Member] | Charter Amendment [Member]
Amount deposit in trust account	111,574,843
Redeem Public Shares	$ 5,000,001
Shares authorized by shareholders	12,391,198
Payment to shareholders, per share price	$ 10.52
Public shares outstanding	10,608,802
Payment to shareholders	$ 130,320,650